Quantifying Unmet Need in Statin-Treated Hyperlipidemia Patients and the Potential Benefit of Further LDL-C Reduction Through an EHR-Based Retrospective Cohort Study-Reference-Cited by-同舟云学术

Quantifying Unmet Need in Statin-Treated Hyperlipidemia Patients and the Potential Benefit of Further LDL-C Reduction Through an EHR-Based Retrospective Cohort Study

Published:2019-05 Issue:5 Volume:25 Page:544-554
ISSN:2376-0540
Container-title:Journal of Managed Care & Specialty Pharmacy
language:en
Short-container-title:JMCP

Author:

Schleyer Titus¹,Hui Siu²,Wang Jane²,Zhang Zuoyi²,Knapp Kristina²,Baker Jarod²,Chase Monica³,Boggs Robert³,Simpson Ross J.⁴

Affiliation:

1. Regenstrief Institute, and Indiana University School of Medicine, Indianapolis.

2. Regenstrief Institute, Indianapolis, Indiana.

3. Merck, Kenilworth, New Jersey.

4. Division of Cardiology, University of North Carolina at Chapel Hill.

Publisher

Academy of Managed Care Pharmacy

Subject

Health Policy,Pharmaceutical Science,Pharmacy

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pragmatic Trial of Messaging to Providers About Treatment of Hyperlipidemia (PROMPT-LIPID): A Randomized Clinical Trial;Circulation: Cardiovascular Quality and Outcomes;2024-05

2. Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention;American Journal of Cardiovascular Drugs;2023-07-24

3. Feasibility of Short-Term Aggressive Lipid-Lowering Therapy with the PCSK9 Antibody in Acute Coronary Syndrome;Journal of Cardiovascular Development and Disease;2023-05-09

4. The N‐Acetylgalactosamine‐conjugated small interfering RNA inclisiran can be coadministered safely with atorvastatin in cynomolgus monkeys resulting in additive low‐density lipoprotein cholesterol reductions;Pharmacology Research & Perspectives;2023-04

5. Rationale and design of a pragmatic trial aimed at improving treatment of hyperlipidemia in outpatients with very high risk atherosclerotic cardiovascular disease: A pragmatic trial of messaging to providers about treatment of hyperlipidemia (PROMPT-LIPID);American Heart Journal;2022-11